India · Delayed Price · Currency is INR NSE:HCG Statistics
Total Valuation
NSE:HCG has a market cap or net worth of INR 94.14 billion. The enterprise value is 106.86 billion.
| Market Cap | 94.14B |
| Enterprise Value | 106.86B |
Important Dates
The last earnings date was Tuesday, May 19, 2026.
| Earnings Date | May 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:HCG has 149.30 million shares outstanding. The number of shares has increased by 1.30% in one year.
| Current Share Class | 149.30M |
| Shares Outstanding | 149.30M |
| Shares Change (YoY) | +1.30% |
| Shares Change (QoQ) | +4.32% |
| Owned by Insiders (%) | 9.41% |
| Owned by Institutions (%) | 19.66% |
| Float | 59.34M |
Valuation Ratios
The trailing PE ratio is 684.12 and the forward PE ratio is 72.29. NSE:HCG's PEG ratio is 0.94.
| PE Ratio | 684.12 |
| Forward PE | 72.29 |
| PS Ratio | 3.70 |
| PB Ratio | 6.68 |
| P/TBV Ratio | 10.33 |
| P/FCF Ratio | 171.15 |
| P/OCF Ratio | 27.12 |
| PEG Ratio | 0.94 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.87, with an EV/FCF ratio of 194.29.
| EV / Earnings | 776.61 |
| EV / Sales | 4.20 |
| EV / EBITDA | 22.87 |
| EV / EBIT | 47.90 |
| EV / FCF | 194.29 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 1.23.
| Current Ratio | 1.12 |
| Quick Ratio | 0.95 |
| Debt / Equity | 1.23 |
| Debt / EBITDA | 3.73 |
| Debt / FCF | 31.55 |
| Interest Coverage | 1.26 |
Financial Efficiency
Return on equity (ROE) is 1.90% and return on invested capital (ROIC) is 7.26%.
| Return on Equity (ROE) | 1.90% |
| Return on Assets (ROA) | 3.71% |
| Return on Invested Capital (ROIC) | 7.26% |
| Return on Capital Employed (ROCE) | 7.63% |
| Weighted Average Cost of Capital (WACC) | 4.52% |
| Revenue Per Employee | 3.78M |
| Profits Per Employee | 20,428 |
| Employee Count | 6,736 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 28.71 |
Taxes
In the past 12 months, NSE:HCG has paid 41.40 million in taxes.
| Income Tax | 41.40M |
| Effective Tax Rate | 15.38% |
Stock Price Statistics
The stock price has increased by +14.93% in the last 52 weeks. The beta is -0.09, so NSE:HCG's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | +14.93% |
| 50-Day Moving Average | 600.91 |
| 200-Day Moving Average | 644.23 |
| Relative Strength Index (RSI) | 51.82 |
| Average Volume (20 Days) | 207,749 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HCG had revenue of INR 25.45 billion and earned 137.60 million in profits. Earnings per share was 0.96.
| Revenue | 25.45B |
| Gross Profit | 9.25B |
| Operating Income | 2.22B |
| Pretax Income | 269.20M |
| Net Income | 137.60M |
| EBITDA | 4.66B |
| EBIT | 2.22B |
| Earnings Per Share (EPS) | 0.96 |
Balance Sheet
The company has 5.41 billion in cash and 17.35 billion in debt, with a net cash position of -11.94 billion or -80.00 per share.
| Cash & Cash Equivalents | 5.41B |
| Total Debt | 17.35B |
| Net Cash | -11.94B |
| Net Cash Per Share | -80.00 |
| Equity (Book Value) | 14.10B |
| Book Value Per Share | 92.07 |
| Working Capital | 1.18B |
Cash Flow
In the last 12 months, operating cash flow was 3.47 billion and capital expenditures -2.92 billion, giving a free cash flow of 550.00 million.
| Operating Cash Flow | 3.47B |
| Capital Expenditures | -2.92B |
| Depreciation & Amortization | 2.44B |
| Net Borrowing | -369.60M |
| Free Cash Flow | 550.00M |
| FCF Per Share | 3.68 |
Margins
Gross margin is 36.36%, with operating and profit margins of 8.71% and 0.54%.
| Gross Margin | 36.36% |
| Operating Margin | 8.71% |
| Pretax Margin | 1.06% |
| Profit Margin | 0.54% |
| EBITDA Margin | 18.30% |
| EBIT Margin | 8.71% |
| FCF Margin | 2.16% |
Dividends & Yields
NSE:HCG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.30% |
| Shareholder Yield | -1.30% |
| Earnings Yield | 0.15% |
| FCF Yield | 0.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:HCG is 779.56, which is 23.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 779.56 |
| Price Target Difference | 23.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 15.18% |
| EPS Growth Forecast (3Y) | 87.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |